Mutations in sulA (sfiA) block the filamentation and death of capR (ion) mutants that occur after treatments that either damage DNA or inhibit DNA replication and thereby induce the SOS response. Previous suiA-iacZ gene fusion studies showed that sulA is transcriptionally regulated by the SOS response system (lexAlrecA). SulA protein has been hypothesized to be additionally regulated proteolytically through the capR (lon) (14) . Most of these inducing treatments correlate with the induction of a cellular response termed the SOS response and imply that the cell division defect associated with the lon mutation is mediated through the SOS response. This response is characterized by enhanced capacity for DNA repair and mutagenesis, prophage induction, and inhibition of cell division (filamentation). Regulation of the SOS response involves two proteins: LexA, the repressor of the SOS inducible operons, and RecA, a protease that is activated by the SOS-inducing signal and specifically cleaves the LexA protein (reviewed in reference 29).
The major phenotypic property of cell division mutants in Escherichia coli is the production of long, nonseptated filamentous cells. Why these mutants filament is a major query in the understanding of cell division in E. coli. One cell division mutant is the lon (or capR) mutant (1, 21, 32, 35, 39, 54) . Ion strains filament as long, nonseptated cells after treatments that damage DNA (UV irradiation, nitrofurantoin [NF] ) or inhibit DNA replication (nalidixic acid, thymine starvation) or even by shifting them from minimal to complex medium (14) . Most of these inducing treatments correlate with the induction of a cellular response termed the SOS response and imply that the cell division defect associated with the lon mutation is mediated through the SOS response. This response is characterized by enhanced capacity for DNA repair and mutagenesis, prophage induction, and inhibition of cell division (filamentation). Regulation of the SOS response involves two proteins: LexA, the repressor of the SOS inducible operons, and RecA, a protease that is activated by the SOS-inducing signal and specifically cleaves the LexA protein (reviewed in reference 29) .
In addition to filamentation, Ion strains show other phenotypic effects such as the overproduction of capsular polysaccharide, i.e., mucoidy (32, 33) and decreased lysogenization of lambda (12, 14, 55) and P1 phages (53) . The Ion mutation also affects the stability of certain abnormal (6, 18, 19, 28, 29, 36, 48) and normal (11, 16, 38, 46) polypeptides.
The lon+ gene has been cloned (47, 57) , and the protein has been purified to homogeneity (9, 56) . It is a tetramer (8) with subunits of 94 kilodaltons (kdal) that has multiple 552 SCHOEMAKER, GAYDA, AND MARKOVITZ because the Lon (CapR) protein is an ATP-dependent protease (9, 10; Charette, Ph.D. thesis) and mutations in lon affect the stability of proteins in vivo, it has been hypothesized that SulA protein is additionally regulated proteolytically via the Lon protease.
Recently, it has been discovered that sulA is closely linked to ompA on the E. coli chromosome (38) , and both sulA (38) and most of ompA (5, 20) are contained on a cloned BamHI fragment (5, 20) that has been sequenced (2). Mizusawa and Gottesman (38) showed that this BamHI fragment, which they cloned into a phage vector, can complement sulA mutants and that the product of the sulA gene is an 18- (38) . The implications, although not specifically mentioned, were that the CapR protease directly proteolyzed the SulA protein. Based on the DNA sequence (2) , the SulA protein is expected to be 18 kdal. The DNA sequence data also confirmed the lexA gene control of the sulA gene, because a LexA protein DNA-binding consensus sequence (SOS box) was found in the promoter region of the sulA gene (2, 38) , although it was not recognized at the time of the original sequehcing (2) .
The ability to manipulate the suIA+ gene with a plasmid enabled us to (i) identify the SulA protein as a nalidixic acidinduced, 18-kdal polypeptide by polyacrylamide gel electrophoresis in sodium dodecyl sulfate (PAGE-SDS); (ii) confirm that the SulA protein is more stable in a Ion mutant; (iii) demonstrate that the SulA protein is membrane associated; (iv) test whether SulA protein is a substrate of the Lon ATPdependent protease; and (v) demonstrate that multicopy plasmids containing suIA+ cause filamentation of lon sulA and lon sulB strains in the absence of an inducer of the SOS response. Furthermore, the suiA+ plasmid could not be established in a lon strain in the absence of either a sulA or a sulB mutation.
MATERIALS AND METHODS
Media and reagents. The media used have been described previously (14, 47) . NF, a drug that mimics UV radiation treatment (14, 22, 57) , was purchased from Sigma Chemical Co. and used at a concentration of 2 ,ug/ml. [3 S]methionine (0.015 mCi/ml, 999 Ci/mmol) was purchased fronm New England Nuclear Corp. Nalidixic acid, bleomycin, and phenylmethylsulfonyl fluoride were purchased from Sigma.
Bacteria and plasmids. The bacterial strains used are listed in Table 1 . The procedures for isolation of covalently closed plasmid DNA and for transformation of bacteria with plasmids were as previously described (47) . For these studies we obtained two sulA+-containing plasmids from U. Henning. Plasmid pTU100 has a 7.5-kilobase EcoRI fragment of E. coli DNA encoding the ompA+ and sulA+ genes cloned in the vector plasmid pSC101 (5) . Plasmid pTU302 has a 1.78-kilobase BamHI fragment encoding the suiA+ gene and the NH2-terminal end of an ompA amber mutant gene (ompA31 [amber mutation at position 7 of the amino acid sequence]) cloned in the multicopy vector pBR322 (2; Fig. 1A ). The fragment of the ompA amber mutant gene was cloned because earlier studies had failed to clone either the entire ompA + gene or the same NH2-terminal fragment of the gene in pBR322, presumably because such multicopy plasmids were lethal to cells (2, 5) . The evidence that these plastnids indeed specify the sulA gene was initially reported by S. Mizusawa and S. Gottesman (38) and is confirmed in this paper. For most of otir experiments we used the high-copy plasmid pTU302.
A (Fig. 1B) . Protein samples and standards were prepared and subjected to PAGE-SDS in one dimension as described previously with approximately equal quantities of total radioactivity in each gel slot (13, 47) . The preparation of cells for twodimensional gel electrophoresis has been described previously (46) , as have the details for the two-dimensional gel electrophoresis used here (3, (41) (42) (43) .
Cell fractionation procedures. Preparation of whole cell extracts, isolation of Sarkosyl-insoluble membranes, and separation of inner and outer membranes by isopycnic sucrose gradients were as described previously (13) . Membranes layered on the isopycnic gradient were obtained by either French pressure cell lysis at 16,000 lb/in2 (49) or sonic disruption. The quick membrane extraction procedure with NaOH precipitation, leaving a subset of inner and outer membrane proteins in the pellet, was as described previously (45) .
The four pTU302-containing strains (RGC103-2, RGC103-9, MC100, and RGC208) induced with nalidixic acid for 90 min and then labeled for 1 min were fractionated as follows. A sample was immediately fractionated by NaOH precipitation (45) . Another sample was chilled and sonicated, and the envelope was separated from soluble cytoplasmic proteins by centrifugation (20,000 x g for 15 min). One half of the envelope fraction was then further solubilized with 1% Sarkosyl for outer membrane localization. The proteins were examined by PAGE-SDS and autoradiography. RESULTS Effects of high sulA gene dosage on various lon strains. We attempted to construct lon, lon sulA, and Ion sulB strains containing the multicopy suiA+ plasmid, pTU302 ( Table 2) . The ability to establish the multicopy sulA+ plasmid pTU302 in a lon mutant might be expected to depend on whether the SulA protein is more stable in the lon cell and, if so, the phenotypic effects of increased sulA+ gene dosage (i.e., whether multiple copies of sulA are lethal to the cell). All strains were grown in minimal medium because in complex medium some lon strains tend to filament and die (14) . After transformation, cells were plated on minimal agar and complex agar with carbenicillin and with or without the drug NF. NF mimics the effects of UV irradiation on Ion cells; it invokes the SOS response in these cells (22) , leading to cell filamentation and death (14) . pTU302 transformants of the lon+ strain MC100 were obtained on all media with no apparent effects of the increased sulA+ gene dosage (com- (57) .
C YET is yeast extract-tryptone (14) . d YET-NF2 is YET supplemented with 2 ,ug of nitrofurantoin per ml.
eThe colony size of these transformants was smaller than that of comparable transformants with pBR322.
VOL. 158, 1984 on January 12, 2018 by guest http://jb.asm.org/ 554 SCHOEMAKER, GAYDA, AND MARKOVITZ pare with and without NF), whereas pTU302 transformants of the isogenic Ion strain RGC103 were not obtained on any of the media (Table 2) . Strain RGC103 was transformable with the cloning vector pBR322 on both minimal and complex media in the same experiments, although the Ion strain did not survive on medium with NF as expected (57) . pTU302 transformants were obtained with the lon sulA and lon sulB strains (Table 2 ). pTU302 transformants of the Ion sulA strain (RGC103-2) grew slowly, producing small colonies on both minimal and complex agar compared to pBR322-transformants. In contrast pTU302-transformants of the Ion sulB strain (RGC103-9) grew almost as well as the control pBR322-transformants. No pTU302 transformants of either Ion sulA or lon sulB were obtained on agar containing NF, although these strains are themselves resistant to NF (14; Table 2 ). Since the sulA gene is inducible by SOSinducing treatments (22) , this sensitivity of pTU302-transformed lon sul strains to NF is consistent with the interpretation that the lethal effects of a high dosage of suIA+ gene after SOS induction cannot be compensated for by a single chromosomal mutation in either sulA or sulB.
Similar transformation results with plasmid pTU302 were obtained for another set of isogenic lon+, lon, and lon sulA strains without suppressors (X7102, RGC123, RGC123-2; Table 3 ).
The results of transformation with plasmids pRGC11 and pRGC13 (Table 3) show that the inability to transform into a capR (lon) strain is a result of the plasmid-localized sulA+ allele. The subcloned sulA+-containing plasmid pRGC11 specifies the suIA+ gene plus only the first 20 amino acids of the ompA protein (still retaining the ompA31 amber mutation at position 7 of the amino acid sequence; Fig. 1C ). No pRGC11 transformants were obtained with the capR (lon) strain, as with pTU302. In contrast, mutating the sulA gene of pTU302 by inserting a mini-Mu transposon, generating plasmid pRGC13 (Fig. 1B) , resulted in viable transformants of the capR (Ion) strain (Table 3) .
We next asked the question: can we introduce the capR9 allele by P1 transduction into a capR+ strain already containing pTU302. The introduction of the capR9 mutation was attempted by P1 phage transduction into a capR+ (X7102) strain containing plasmid pTU302 by selecting for proC+ transductants and scoring for capR9 (mucoid phenotype). In such an experiment in which 380 proC+ transductants were screened, no mucoid proC+ transductants of X7102(pTU302) were obtained, whereas with strains X7102 and X7102(pBR322), 10% of the proC+ transductants were mucoid. Thus it appears that even when the plasmid pTU302 is stable the introduction of a capR9 allele produces a nonacceptable combination. A further characterization of this phenomenon is presented in a later section. Table 2 , footnote b).
Phenotypic effects of the sulAU plasmid. If the SulA protein by itself is an inhibitor of cell division and is more stable in Ion strains, then the introduction of a high-copy suiA+ plasmid might mimic UV irradiation or other SOS-inducing treatments by causing Ion cells to filament. Since pTU302-transformants of Ion mutants are not viable, we examined pTU302 transformants of lon sulA (RGC103-2) and lon sulB (RGC103-9) as well as lon+ (MC100) cells. pBR322 transformants of these strains were also examined. All transformed strains were grown in minimal medium to the midexponential phase. As a filamentation control a sample of each culture was also treated with nalidixic acid for 120 min to induce the SOS response and filaments. The cells were examined by phase-contrast microscopy. Even without nalidixic acid treatment, the pTU302-transformed lon sulA and lon sulB populations (Fig. 2B and D, respectively) contained many large filamentous cells compared with the control populations transformed with pBR322 ( Fig. 2A and C) .
The lon sulB mutant with (Fig. 2C ) or without pBR322 (data not shown) is always elongated compared with the lon sulA mutant ( Fig. 2A) in the absence of an SOS-inducing treatment when salt concentration is low (17, 26) as in minimal medium. pTU302-transformed strains treated with nalidixic acid for 120 min were not substantially more filamentous than the untreated cells (data not shown), although this type of treatment is lethal. Thus, the introduction of a multicopy sulA+ plasmid causes cell filamentation in Ion sulA and lon sulB strains without any apparent SOS response.
Identification of the SulA protein specified by plasmid pTU302. Plasmid pTU302 was transformed into the minicellproducing strain DS410 to identify the sulA product specified by pTU302. We were also able to obtain viable pTU302 transformants of a lon (capR6) strain that produces minicells (designated Lon Min) because the capR6 mutation has residual lon function (more UV resistance) as compared with the capR9 allele (34) . Minicells were isolated, labeled for 10 min at 37°C with [35S]methionine, and then diluted into cold buffer containing excess L-methionine and the protease inhibitor phenylmethylsulfonyl fluoride. A short labeling time was chosen because: (i) the SulA protein is less stable in wild-type bacterial strains (38) , and (ii) the SulA protein was not detected when pTU100 plasmid-containing minicells were labeled for 2 h (2, 5). In Fig. 3 , the SulA protein can be identified as the major unique band specified by plasmid pTU302 (Fig. 3, compare lanes 1, 2) . It has a molecular mass of 18 kdal. The other major polypeptide bands are specified by the cloning vector pBR322 and include the 3-lactamase that migrates as 31-and 28-kdal polypeptides. We found no enhancing effects of the SOS-inducing drugs nalidixic acid or bleomycin on the expression of the sulA gene in isolated minicells (Fig. 3, lanes 1, 3, and 4) . The presence of PMSF during the labeling period did not increase the relative amount of SulA protein (Fig. 3, lanes 1 and 5) . In addition, the SulA protein was synthesized in Lon Min minicells containing pTU302 (Fig. 3, lanes 6 and 7) and in DS410 minicells containing the pTU100 plasmid (Fig. 3, lane 8) , which also specifies the complete OmpA protein, protein II*. This latter protein is visible (33 kdal) along with a slightly larger polypeptide that is the precursor of protein II* (20) .
The Lon Min(pTU302) strain shows several additional polypeptide bands including two polypeptides with molecular masses of approximately 29 kdal (just above the 28-kdal ,-lactamase polypeptide) and 24 kdal that are not visible in DS410(pTU302) (Fig. 3, compare lanes 5 and 6) . They are polypeptides resulting from suppression of the amber allele of the ompA cloned fragment because (i) the Lon Min strain contains a suppressor (11), (ii) the polypeptides are not visible in the control, Lon Min(pBR322) (Fig. 3, lane 7) , and (iii) Bremer et al. reported the appearance of polypeptides with apparent molecular masses of 30 and 24 kdal in the envelopes of pTU302-transformed supD or supF strains that were absent in nonsuppressing strains (5). They also provided evidence that the larger polypeptide is a precursor of the 24-kdal polypeptide (5 (Fig. 4, lane 10) . SulA protein was not detected in the absence of nalidixic acid treatment of Ion sulB or Ion sulA strains containing the suiA+ plasmid pTU302 (Fig. 4 , lanes 5 and 6; Fig. 5, lane 7) . However, it was visible in these strains after the 1 h of nalidixic treatment [Fig. 4 , lanes 7 through 9, Ion sulB(pTU302); Fig. 5 , lanes 8 and 9, Ion sulA(pTU302)]. SulA protein was also visible after nalidixic acid treatment of the Ion sulB strain containing the other suIA+ plasmid, pTU100 (Fig. 4, lanes 11 through 14) . Fig. 2 . Lanes: 1 to 4, RGC103-9(pBR322) incubated with nalidixic acid for 0, 1, 2, and 4 h, respectively, before [35S]methionine labeling; 5 to 9, RGC103-9(pTU302) incubated without nalidixic acid for 2 h (lane 5) and 0 h (lane 6) and with nalidixic acid for 1, 2, and 4 h (lanes 7, 8, 9, respectively) before labeling; 10, minicell DS410 (pTU302) as a standard for sulA specified protein; 11 to 14, RGC103-9(pTU100) incubated with nalidixic acid for 0, 1, 2, and 4 h, respectively, before labeling. this strain does not appear to be synthesized in higher amounts (Fig. 4 SulA protein was also observed, albeit to a lesser extent, in the nalidixic acid-treated Ion sulB haploid strain containing only the control plasmid pBR322 (Fig. 4 , lanes 2 through 4; Fig. 5, lanes 2 and 3) . This observation allowed us to examine a nalidixic acid-induced, haploid lon sulA strain for either lack of SulA protein or an altered SulA protein.
Although an SOS response appears to have occurred, since newly induced proteins were visible (Fig. 5, arrow) , no SulA protein was induced in this strain (Fig. 5, lanes 4 through 6) . The fact that a sulA mutant strain lacks an inducible 18-kdal polypeptide supports the identification of the 18-kdal polypeptide as the sulA gene product. Whether this sulA mutant produces a truncated polypeptide is unknown, as we did not resolve any smaller inducible polypeptide. Stability of SulA protein in vivo. To examine the hypothesis that the SulA protein is more stable in a Ion background, we induced with nalidixic acid and labeled the SulA protein in a Ion+ strain containing the sulA+ plasmid pTU302.
By decreasing the labeling time to 1 min, the SulA protein was indeed induced and amplified in the lon+ strain (Fig. 6 , lane 5). Furthermore, when the labeled SulA protein itf the lon+ strain was chased for 5 min by the addition of medium containing an excess of L-methionine, very little SulA protein was detected on the autoradiogram, and none was visible after a chase of 20 min. In contrast, a significant amount of SulA protein was detectable in the Ion sulB(pTU302) strain that was labeled for 1 min and chased for up to 20 min (Fig. 6, lanes 2 and 3; 30 min. The majority of the SulA protein remained with the envelope fraction (Fig. 7, lanes 1 and 2) . The labeled cell envelope was further fractionated by the classical membrane procedure of isopycnic sucrose gradient centrifugation (Fig.  8) . In this procedure the outer membrane equilibrates at a density of 1.22 g of sucrose per ml, and the inner membrane equilibrates at a density of 1.17 to 1.16 g of sucrose per ml. Soluble proteins float on the top of the gradient. Electrophoresis of the labeled protein from such a membrane fractionation is shown in Fig. 7 . Labeled SulA protein is found in the outer membrane fraction (Fig. 7, lanes 3 and 7) . A small amount of SulA protein relative to the other labeled proteins was also found in the inner membrane fraction and with the proteins floating on top of the gradient (Fig. 7, lanes 4  through 6) .
Nalidixic acid-induced and labeled RGC103-9(pTU302) cells were also fractionated based on alkali (NaOH) sedimentation. Proteins derived from the inner and outer membrane remain insoluble for the most part (45) . Most proteins partition unambiguously (45) . A large portion of SulA protein was NaOH precipitable; however, some SulA protein was also in the supernatant fraction. In no case was there less than 50% of the SulA protein in the precipitable fraction. The 18-kdal 35S-labeled protein band identified in both the precipitable and supernatant fractions of RGC103-9(pTU302) is unstable, since that protein band decreased compared with other protein bands after a 20-min chase (Fig.  9) . This is consistent with the increased lability of the SulA protein even in a capR mutant.
SulA protein localization in the envelope was additionally Is SulA protein a substrate of the Lon ATP-dependent protease? The simplest current model of lon-sulA interaction predicts that SulA protein is a substrate of the Lon protease. Although the SulA protein was localized to the cellular membrane, we still tested its susceptibility to the soluble Lon protease in vitro. As described above, we prepared a cell envelope fraction that was enriched for the SulA protein.
The envelope was suspended in buffer with or without 0.3% Triton X-100 and then added to an assay along with the purified Lon protease and ATP. In the assay with Triton X-100 the final concentration was 0.03%. As a control, the envelope preparations were mixed in equal protein concentration with a lon cell extract containing radioactive protein a, an acidic 11-kdal polypeptide. This protein is degraded in a similar in vitro assay upon the addition of the purified Lon protease and ATP (46) .
The assays were incubated at 37°C for 90 min, and then proteins were analyzed by two-dimensional gel electrophoresis. Only protein a (the control) was detectably degraded (data not shown). In other experiments with one-dimensional PAGE-SDS, the SulA protein that was present in the soluble fraction was also not degraded by the Lon protease, although these conditions would support proteolysis of casein by Lon protease. Since the SulA protein was not degraded under conditions in which protein a and casein were, we concluded that SulA protein may not be a direct substrate of Lon protease. Alternatively, other conditions than we have tested may be required for Lon protease to degrade the SulA protein in addition to factors necessary for protein a or casein digestion (i.e., modification of the SulA protein, unidentified small molecule cofactors, or other protein or nucleic acid factors or absence of inhibitors). Further studies are required to decide among these possibilities.
Why can you establish the multicopy suU+' plasmid in a Ion suL4 strain, but not in a Ion sulA+ strain, when the amount of wild-type SulA protein would be expected to be approximately equivalent in the two strains? Five possibilities were considered.
Since some sulA mutations are dominant (12, 27) it is possible that a putative chromosomal SulA mutant protein is anticomplementing (8) some of the plasmid-coded SulA wildtype protein, thereby modifying the lethal effects of multiple copies of the latter. We tested seven other independent sulA mutations in two lon backgrounds (derivatives of MC100 and X7102), and all yielded transformants with pTU302. If we had found one sulA allele giving no transformants the data would have supported this interpretation. This alternative would require the unlikely assumption that a chromosomal (single-copy) allele be dominant to a wild-type allele present in multiple copies.
Another alternative is that when pTU302 (sulA+) is transformed into a capR9 sulA strain the transformants that survive are in fact homogenotes of the mutant sulA allele that arose by recombination. This explanation seems unlikely from the following data: the transformation frequency of pTU302 into the capR9 sulA2 strain is identical to that obtained with the capR9 suiB9 strain (Table 2) . Furthermore the phenotype of the capR9 suIA2(pTU302) (sulA+) is easily distinguished from the capl?9 sulA2(pTU302)::mini-Mu(suiA inserted); the former is filamentous (Fig. 2) , grows poorly on minimal medium, and is NF sensitive (Table 2) , whereas the latter grows well on minimal medium and is NF resistant.
Another alternative is that chromosomal sulA mutants exert a polar effect on the following adjacent ompA gene, which is transcribed in the same direction (Fig. 1) (37) . The relative activities were as follows: capR+(pRGC13), 1.0; capR9 suiAJ2(pRGC13), 4.0; capR9 suiA+(pRGC13), 2.0; capR82(pRGC13), 1.6 . There is a higher differential rate of synthesis of sulA promoter-controlled ,-galactosidase in the capR mutants compared with the capR wild type. However, according to the stated hypothesis, the capR9 sulA+ strain should have been higher than the capR9 suiA12 strain to account for lethality, and the reverse is true if there is any difference; thus this hypothesis is not supported by the data. Incidentally, the differences in 3-galactosidase activity reported here between capR+ and capR9 strains are likely to reflect a difference in plasmid copy number since Huisman and D'Ari reported that with 3-galactosidase inserted into the chromosomal (single-copy) sulA gene there is no difference in ,B-galactosidase synthesis in capR+ and capR mutants (22) .
Since none of the above hypotheses is supported by the data, another alternative we consider is the following. Another unknown protein increases in capR9 sulA mutants (in contrast to the capR9 sulA+ strain) that somehow overcomes the lethality caused by plasmid-coded copies of sulA'. Further understanding of the molecular function of the SulA protein is required before it would appear worthwhile to investigate such an hypothesis.
DISCUSSION
Previous suiA-lacZ gene fusion studies showed that the sulA gene is transcriptionally regulated by the SOS regponse system (lexA/recA) (22) . Our results demonstrate that SulA protein synthesis is induced by nalidixic acid. Thus, the SulA protein is induced along with the products of the other SOS genes (uvrA, uvrB, umuC, IexA, recA, etc.) under LexA repressor control (29) . A hypothesis to explain the lon cell division defect would involve the SOS response (22, 29) , the sulA+ gene, and the SulA protein's increased stability in a lon mutant (38) (Fig. 6 ) and the rarity of specific protein instability (39, 46) (38) . However, there is no apparent N-terminal amino acid signal sequence specified by that sulA gene nucleotide sequence (2) . The pulse-chase experiments on the instability of the SulA protein in the membrane and soluble fractions (NaOH technique) demonstrated that SulA protein was unstable in both fractions (Fig. 9) . Nevertheless, there was no indication of larger intermediates in the experiments of The SulA protein may act in the membrane or soluble fraction to inhibit septation. The sulB gene has recently been reported to be an allele of ftsZ (30) . Only temperaturesensitive lethal mutants of ftsZ have been described previously, and these form nonseptate filaments at high temperature and die (31) . Thus the sulB (ftsZ) gene is an essential gene. The SulA protein could be functioning by inhibiting the synthesis of the SulB protein (SulA protein as a soluble repressor) or by inhibiting the activity of the SulB protein (SulA protein in the soluble or membrane fraction). Although the SulB protein is a candidate for a protein whose synthesis or activity is inhibited by the SulA protein, others are not excluded and are equally possible, for example, penicillin-binding protein 3, a membrane-localized transpeptidase and transglycosylase (25) also known to be required for septum formation (4, 50, 52) .
A level of excess SulA protein that results in cell lethality was achieved in both lon sulA and Ion sulB strains when pTU302 (sulA+) transformants were plated on nitrofurantoin ( (46) suggests the Lon protein is also dispensible. Alternatively, both the SulA and Lon proteins may participate in normal cell division, but have backup mechanisms that substitute for them as is the case with other crucial cellular processes (40) . In either case it seems likely that the SulA protein is interacting to inhibit synthesis or activity of protein(s) involved in normal septation (during the SOS response) and should therefore be a useful tool to further study the biochemistry of normal cell division. 
